Close
Country websites:

Volume control - three steps for better volume control

steps for better volume control

Volume control in PD

Doctor holding filter

A practical way to assess and help correct fluid status

  • Quickly assess fluid status and recognize the trend
  • Make therapeutic changes earlier
  • Effortlessly use a wider range of practical volume control tools
  • Key features
  • Studies

Assess status and trend

BCM-Body Composition Monitor
BCM-Body Composition Monitor

Routinely assess fluid status
The easy-to-use BCM-Body Composition Monitor is a powerful addition to the routine evaluation of your patients and is becoming a standard in leading PD centers.

By providing you with a more precise picture of actual fluid status through quantified overhydration, this state-of-the-art technology helps you manage the fluid status of your patients better. 

Analyze the fluid status trend
The BCM-Body Composition Monitor can be used effectively to continually monitor changes and trend of the fluid status over time. Trend analysis can provide important feedback and guidance on therapy decision-making by you and your staff1.

Volume status improvement as a result of awareness

Optimize output

Adapted PD promotes both the process of UF and clearance

EuroBCM Study maintaining euvolemia in PD

Important factors to consider in fluid status:

Fluid status is mainly the result of the balance of intake and output over time
World map with Fresenius Medical Care locations

Details about Fresenius Medical Care products

To learn more about our products please visit your country website.

Related Content

1 Van Biesen W, Williams JD, Covic AC, Fan S, Claes K, et al. (2011) Fluid Status in Peritoneal Dialysis Patients: The European Body Composition Monitoring (EuroBCM) Study Cohort. PLoS ONE 6(2): e17148. doi:10.1371/journal.pone.0017148.

2 Luo Y, Lu X, Woods F, Wang T. Volume Control in Peritoneal Dialysis Patients Guided by Bioimpedance Spectroscopy Assessment. Blood Purification 2011;31:296-302.

3 Fischbach M, Issad B, Dubois V, and Taamma R. The beneficial influence on the effectiveness of automated peritoneal dialysis of varying the dwell time (short/long) and fill volume (small/large): randomized controlled trial. Peritoneal Dialysis International 2011; 31(4):450-8.

4 Kim S, Oh J, Kim S, Chung W, Ahn C, Kim SG, Oh KH. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study. Nephrology Dialysis Transplantation2009;24(9):2899-90.

5 Haag-Weber M, Krämer R, Haake R, Islam MS, Prischl F, Haug U, Nabut JL, Deppisch R. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study. On behalf of the DIUREST Study Group. Nephrology Dialysis Transplantation 2010;25(7):2288-96.

6 Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C,Passlick-Deetjen J; Euro Balance Trial Group. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney International 2004;66(1):408-18.

7 Weiss L, Stegmayr B, Malmsten G, Tejde M, Hadimeri H, Siegert CE, Ahlmén J, Larsson R, Ingman B, Simonsen O, van Hamersvelt HW, Johansson AC, Hylander B, Mayr M, Nilsson PH, Andersson PO, De los Rios T. Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution. Peritoneal Dialysis International 2009;29(6):630-633.

8 Rippe B, Simonsen O, Heimbürger O, Christensson A, Haraldsson B, et al. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney International 2001;59(1):348-57.